We are live on ! Find out more
NURO

NeuroMetrix, Inc. Common Stock

Delisted

NURO was delisted on the 1st of May, 2025.

13 hedge funds and large institutions have $423K invested in NeuroMetrix, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

8% more funds holding

Funds holding: 1213 (+1)

45% less capital invested

Capital invested by funds: $776K → $423K (-$353K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 4

Holders
13
Holders Change
+1
Holders Change %
+8.33%
% of All Funds
0.2%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
Reduced
4
Closed
1
Calls
Puts
Net Calls
Net Calls Change

NURO Hedge Fund Activity: Q2 2023 in Review

13 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in NeuroMetrix, Inc. Common Stock (NURO) for Q2 2023, worth a combined $423K — down 45% from $776K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new NURO positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 4 trimmed.

The largest buyer was HRT Financial, opening a new position worth an estimated $30.7K. The largest seller was Vanguard Group, cutting an estimated $114K.

  • 13 institutional investors held NeuroMetrix, Inc. Common Stock (NURO) as of Q2 2023, up from 12 in Q1 2023.
  • Funds reported $423K of NeuroMetrix, Inc. Common Stock stock for Q2 2023, down 45% quarter-over-quarter.
  • 2 funds opened new NeuroMetrix, Inc. Common Stock positions in Q2 2023 and 1 closed out, a net change of +1 holder.
  • The largest NeuroMetrix, Inc. Common Stock buyer in Q2 2023 was HRT Financial, an estimated $30.7K added.
  • The largest NeuroMetrix, Inc. Common Stock seller in Q2 2023 was Vanguard Group, an estimated $114K sold.

Based on aggregated 13F filings for Q2 2023.